19-21 January 2023 - Short oral presentation
2023 ASCO Gastrointestinal Cancers Symposium
Presentation of the GONO Infinity project at the congress.
INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).
- San Francisco, California
Authors
Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi, Sabina Murgioni, Giovanni Gerardo Cardellino, Stefano Tamberi, Antonia Strippoli, Federica Palermo, Michele Prisciandaro, Giovanni Randon, Francesca Corti, Francesca Bergamo, Floriana Nappo, Alberto Giovanni Leone, Giuseppe Leoncini, Giovanna Sabella, Kristiyana Kaneva, Carlo Sposito, Maria Di Bartolomeo, Vincenzo Mazzaferro.
Mention
DOI: 10.1200/JCO.2023.41.4_suppl.358 Journal of Clinical Oncology 41, no. 4_suppl (February 01, 2023) 358-358.
– https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.4_suppl.358?af=R
